263 related articles for article (PubMed ID: 9232516)
21. Molecular weight-dependent paracellular transport of fluorescent model compounds induced by palmitoylcarnitine chloride across the human intestinal epithelial cell line Caco-2.
Chao AC; Taylor MT; Daddona PE; Broughall M; Fix JA
J Drug Target; 1998; 6(1):37-43. PubMed ID: 9769019
[TBL] [Abstract][Full Text] [Related]
22. HEC-cysteamine particles: influence of particle size, zeta potential, morphology and sulfhydryl groups on permeation enhancing properties.
Rahmat D; Müller C; Shahnaz G; Leithner K; Laffleur F; Khan MI; Martien R; Bernkop Schnürch A
Drug Dev Ind Pharm; 2013 Sep; 39(9):1338-45. PubMed ID: 22901004
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of paracellular transport of heparin disaccharide across Caco-2 cell monolayers.
Cho SY; Kim JS; Li H; Shim C; Linhardt RJ; Kim YS
Arch Pharm Res; 2002 Feb; 25(1):86-92. PubMed ID: 11885699
[TBL] [Abstract][Full Text] [Related]
24. Combining Chemical Permeation Enhancers for Synergistic Effects.
du Toit T; Malan MM; Lemmer HJ; Gouws C; Aucamp ME; Breytenbach WJ; Hamman JH
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):575-86. PubMed ID: 25939330
[TBL] [Abstract][Full Text] [Related]
25. The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like Caco-2 cells.
Jewell C; Cashman KD
Br J Nutr; 2003 May; 89(5):639-47. PubMed ID: 12720584
[TBL] [Abstract][Full Text] [Related]
26. Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells.
Tomita M; Hayashi M; Awazu S
J Pharm Sci; 1996 Jun; 85(6):608-11. PubMed ID: 8773957
[TBL] [Abstract][Full Text] [Related]
27. Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan enhances paracellular permeability across Caco-2 cells.
Kowapradit J; Opanasopit P; Ngawhirunpat T; Rojanarata T; Ruktanonchai U; Sajomsang W
Drug Deliv; 2010 Jul; 17(5):301-12. PubMed ID: 20302396
[TBL] [Abstract][Full Text] [Related]
28. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
29. Absorption-enhancing mechanism of sodium caprate and decanoylcarnitine in Caco-2 cells.
Tomita M; Hayashi M; Awazu S
J Pharmacol Exp Ther; 1995 Feb; 272(2):739-43. PubMed ID: 7853188
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds.
Masungi C; Borremans C; Willems B; Mensch J; Van Dijck A; Augustijns P; Brewster ME; Noppe M
J Pharm Sci; 2004 Oct; 93(10):2507-21. PubMed ID: 15349960
[TBL] [Abstract][Full Text] [Related]
31. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
[TBL] [Abstract][Full Text] [Related]
32. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
33. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
34. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
Brayden DJ; Walsh E
AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
[TBL] [Abstract][Full Text] [Related]
35. Rhamnolipids enhance epithelial permeability in Caco-2 monolayers.
Jiang L; Long X; Meng Q
Int J Pharm; 2013 Mar; 446(1-2):130-5. PubMed ID: 23402975
[TBL] [Abstract][Full Text] [Related]
36. Difructose anhydride III and sodium caprate activate paracellular transport via different intracellular events in Caco-2 cells.
Suzuki T; Hara H
Life Sci; 2006 Jun; 79(4):401-10. PubMed ID: 16566947
[TBL] [Abstract][Full Text] [Related]
37. Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition.
Gleeson JP; Frías JM; Ryan SM; Brayden DJ
Eur J Pharm Biopharm; 2018 Jul; 128():179-187. PubMed ID: 29684535
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of intestinal model compound transport by DS-1, a modified Quillaja saponin.
Chao AC; Nguyen JV; Broughall M; Recchia J; Kensil CR; Daddona PE; Fix JA
J Pharm Sci; 1998 Nov; 87(11):1395-9. PubMed ID: 9811496
[TBL] [Abstract][Full Text] [Related]
39. Transport of insulin in modified Valia-Chien chambers and Caco-2 cell monolayers.
Tang C; Yu J; Yin L; Yin C; Pei Y
Drug Dev Ind Pharm; 2007 Apr; 33(4):449-56. PubMed ID: 17523009
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
